Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. (COYA) is a healthcare company (biotechnology) based in the United States. The share price is $3.03, up 1.00% on the day, which values the company at $71.08M. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$3.03+1.00% today
Market value
$71.08M
Funk Score
34/100
Against its own history
Well below its usual priceusual price $5.82
200-week average
$5.6847% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Coya Therapeutics, Inc. in more detail

COYA trades at -1.5× next year's expected earnings, 15.2× sales. Measured against its own history, the price is 48% below what its usual multiples would imply ($5.82) — well below its usual price. It sits 47% below its 200-week average of $5.68.

Its Funk Score is 34 out of 100 (financial strength 5.3, profitability 0.0, value 5.0, each out of 10).

In its favour: Altman Z in the safe zone. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold COYA, including David Einhorn (0.3% of the portfolio).

Superinvestors holding COYA

1 of the investors tracked here report a position in their latest 13F filing.

Coya Therapeutics, Inc. (COYA): questions and answers

What is Coya Therapeutics, Inc.'s market cap?

Coya Therapeutics, Inc. is valued at $71.08M at a share price of $3.03.

Is COYA overvalued or undervalued?

Against its own history, COYA is well below its usual price: the price is 48% below the $5.82 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is COYA above its 200-week moving average?

No. COYA is 46.7% below its 200-week average of $5.68. Long-term investors watch that line because strong companies rarely trade below it for long.

Does COYA pay a dividend?

Coya Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own COYA?

In their latest quarterly filings, David Einhorn (0.3% of the portfolio) hold COYA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Coya Therapeutics, Inc. (COYA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COYA

Underlying data: Yahoo Finance; company filings with the SEC.